It is my hope that the cancer field continues to grow the novel therapy for not only patients with lung cancer, but well beyond. It is critical that the public be aware of how research and clinical trials are catalysts to better the outcomes of patients with cancer.
Targeted therapies offer new hope for patients with HER2-mutated non-small cell lung cancers.
A patient with stage 4 lung cancer explains why Dr. Shirish Gadgeel is a ray of sunshine and hope who makes patients with cancer feel that living a long life is a possibility.
Christine Eastep demonstrates the highest commitment to every one of the patients and her staff to improve the outcomes in lung cancer treatment, with a commitment to sending her staff nurses to tobacco cessation classes.
Dr. Roy H. Decker is a lung cancer hero — a “triple threat” in lung radiation oncology as a clinical innovator, teacher and ground-breaking clinical trialist, explains a colleague.
Recent results may lead to more checkpoint inhibitor options and lower treatment prices, giving accessibility to more patients with lung cancer worldwide.
Imfinzi plus platinum-pemetrexed chemotherapy induced survival improvements in patients with previously untreated, unresectable malignant pleural mesothelioma, compared with chemotherapy alone.
Twenty years after 9/11, a retired firefighter reflects on the weeks following the attacks, as well as his own diagnosis of lung cancer six years later, in a newly published book.
Looking deeper into mortality rates highlights the importance of eliminating disparities in lung cancer and expanding screening eligibility for at-risk populations.
"Having been newly diagnosed myself, I saw how amazingly well she was doing and had been a survivor for about three years already," a lung cancer survivor writes about a connection she made with another survivor.
A patient with lung cancer explains how Terri Conneran, a patient advocate, helped her understand her disease and fight for proper care in a country with less options.
A lung cancer survivor shares a heartfelt tribute to Dr. Abraham Chachoua, who changed his life.
Two new FDA approvals for patients with lung cancer and EGFR exon 20 insertion mutations have given the subset its first targeted therapies.
Out of the darkness there is sometimes light, and in South Florida, Dr. Mark Block is a beacon of hope and light for many patients who’ve recently received a diagnosis of cancer.
On this episode of the “Cancer Horizons” podcast, a young mother living with lung cancer shares the story of her cancer diagnosis and describes the once-in-a-lifetime coincidence of learning her neighbor has the same cancer type and mutation.
In an era of trauma, people whose buoyancy elevates both purpose and agency shine like a flashlight in the darkness. During the past year of uncertainty, Dave Bjork was that light for many.
One cancer survivor's garden helped her to cope and stay active during diagnosis, through treatment and into remission.
Studies show that quitting smoking after a lung cancer diagnosis has a huge payoff for patients. Many smoking cessation programs in cancer centers have tools to help patients quit.
The majority of Americans lack understanding of lung cancer’s deadly threat and how it can be screened for, according to new survey data from the American Lung Association. One survivor and one patient stress the importance of learning more about the deadliness of the disease.
Upal Basu Roy has a true gift of being able to think from his heart. He educates the patient community, helps patients navigate the fragmented system, fights for drug access issues in other countries, addresses disparities and supports patient-driven initiatives in research and advocacy.
Lung cancer is a dangerous and often silent killer for the residents of northeast Georgia. For Dr. Arfoosh, lung cancer screening, quick referrals and prompt treatment for people with newly diagnosed lung cancer are at the forefront of his daily work.
After Kelsey Ahmed’s mother, Martha, was diagnosed with stage 4 non-small cell lung cancer, Kelsey and her family got to work raising funds and spreading awareness for the American Lung Association.
Patients who experience side effects due to immune checkpoint inhibitors are 80% more likely to go to the emergency room and have 30% higher monthly medical costs, compared to patients who did not have side effects.
In this episode of CURE’s “Cancer Horizons” podcast, three individuals, who were recognized as CURE Lung Cancer Heroes, spoke about what the honor means to them and bringing the lung cancer community together.
By creating a community of survivors, researchers, physicians and clinicians, The White Ribbon Project — under Heidi Nafman-Onda’s direction — has influenced real change.
